chr15-74720496-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001319217.2(CYP1A1):c.1532G>T(p.Arg511Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00128 in 1,566,008 control chromosomes in the GnomAD database, including 54 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00091 ( 8 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 46 hom. )
Consequence
CYP1A1
NM_001319217.2 missense
NM_001319217.2 missense
Scores
4
7
7
Clinical Significance
Conservation
PhyloP100: 6.29
Genes affected
CYP1A1 (HGNC:2595): (cytochrome P450 family 1 subfamily A member 1) This gene, CYP1A1, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by some polycyclic aromatic hydrocarbons (PAHs), some of which are found in cigarette smoke. The enzyme's endogenous substrate is unknown; however, it is able to metabolize some PAHs to carcinogenic intermediates. The gene has been associated with lung cancer risk. A related family member, CYP1A2, is located approximately 25 kb away from CYP1A1 on chromosome 15. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.007909983).
BP6
Variant 15-74720496-C-A is Benign according to our data. Variant chr15-74720496-C-A is described in ClinVar as [Benign]. Clinvar id is 788807.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000913 (139/152280) while in subpopulation SAS AF= 0.028 (135/4828). AF 95% confidence interval is 0.0241. There are 8 homozygotes in gnomad4. There are 108 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CYP1A1 | NM_001319217.2 | c.1532G>T | p.Arg511Leu | missense_variant | 7/7 | ENST00000379727.8 | |
CYP1A1 | NM_000499.5 | c.1532G>T | p.Arg511Leu | missense_variant | 7/7 | ||
CYP1A1 | NM_001319216.2 | c.1445G>T | p.Arg482Leu | missense_variant | 6/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CYP1A1 | ENST00000379727.8 | c.1532G>T | p.Arg511Leu | missense_variant | 7/7 | 1 | NM_001319217.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000907 AC: 138AN: 152162Hom.: 8 Cov.: 32
GnomAD3 genomes
AF:
AC:
138
AN:
152162
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00210 AC: 444AN: 211494Hom.: 8 AF XY: 0.00262 AC XY: 293AN XY: 111858
GnomAD3 exomes
AF:
AC:
444
AN:
211494
Hom.:
AF XY:
AC XY:
293
AN XY:
111858
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00132 AC: 1860AN: 1413728Hom.: 46 Cov.: 30 AF XY: 0.00183 AC XY: 1278AN XY: 697754
GnomAD4 exome
AF:
AC:
1860
AN:
1413728
Hom.:
Cov.:
30
AF XY:
AC XY:
1278
AN XY:
697754
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000913 AC: 139AN: 152280Hom.: 8 Cov.: 32 AF XY: 0.00145 AC XY: 108AN XY: 74454
GnomAD4 genome
AF:
AC:
139
AN:
152280
Hom.:
Cov.:
32
AF XY:
AC XY:
108
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
296
Asia WGS
AF:
AC:
38
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 13, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;D;D;D;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T;T;.;.;.
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
.;.;M;M;M;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Benign
T
PROVEAN
Uncertain
.;.;D;D;D;D
REVEL
Uncertain
Sift
Uncertain
.;.;D;D;D;D
Sift4G
Pathogenic
D;D;D;D;D;D
Polyphen
0.99
.;D;D;D;D;D
Vest4
MutPred
0.56
.;.;Loss of disorder (P = 0.0822);Loss of disorder (P = 0.0822);Loss of disorder (P = 0.0822);.;
MVP
MPC
0.23
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at